Anacor Pharmaceuticals , Nasdaq: ANAC
Developing treatments for nail fungus and psoriasis using boron-based chemistry.
Industry: Health Care
First Day Return: +1.8%
| IPO Data | |
|---|---|
| IPO Date | 11/23/2010 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $60 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Palo Alto, CA, United States |
| Founded | 2000 |
| Employees at IPO | 60 |
| Website www.anacor.com | |
Anacor Pharmaceuticals (ANAC) Performance
